Voya Investment Management LLC Revance Therapeutics, Inc. Transaction History

Voya Investment Management LLC

  • $78.9 Billion
  • Q4 2024

A detailed history of Voya Investment Management LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 31,975 shares of RVNC stock, worth $82,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,975
Previous 34,158 6.39%
Holding current value
$82,175
Previous $87,000 5.75%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
N/A
-2,183 Reduced 6.39%
31,975 $82,000
Q3 2024

Feb 07, 2025
SELL
$2.57 - $2.57 $3,150 - $3,150
-1,226 Reduced 3.46%
34,158 $87,000
Q3 2024

Nov 14, 2024
SELL
$2.57 - $2.57 $3,150 - $3,150
-1,226 Reduced 3.46%
34,158 $87,000
Q2 2024

Feb 07, 2025
BUY
$2.34 - $4.73 $15,486 - $31,303
6,618 Added 23.01%
35,384 $90,000
Q2 2024

Dec 03, 2024
BUY
$2.34 - $4.73 $2,868 - $5,798
1,226 Added 3.59%
35,384 $90,000
Q2 2024

Aug 14, 2024
BUY
$2.34 - $4.73 $15,486 - $31,303
6,618 Added 23.01%
35,384 $90,000
Q1 2024

Feb 07, 2025
SELL
$4.65 - $9.31 $25,072 - $50,199
-5,392 Reduced 15.79%
28,766 $141,000
Q1 2024

Dec 06, 2024
SELL
$4.65 - $9.31 $25,072 - $50,199
-5,392 Reduced 15.79%
28,766 $141,000
Q1 2024

May 15, 2024
SELL
$4.65 - $9.31 $25,272 - $50,599
-5,435 Reduced 15.89%
28,766 $141,000
Q4 2023

Feb 07, 2025
BUY
$5.81 - $11.2 $3,968 - $7,649
683 Added 2.04%
34,201 $300,000
Q4 2023

Feb 14, 2024
BUY
$5.81 - $11.2 $3,968 - $7,649
683 Added 2.04%
34,201 $300,000
Q3 2023

Feb 07, 2025
BUY
$11.47 - $25.07 $4,507 - $9,852
393 Added 1.19%
33,518 $384,000
Q3 2023

Nov 14, 2023
BUY
$11.47 - $25.07 $4,507 - $9,852
393 Added 1.19%
33,518 $384,000
Q2 2023

Feb 07, 2025
BUY
$24.7 - $37.61 $64,294 - $97,898
2,603 Added 8.53%
33,125 $838,000
Q2 2023

Aug 14, 2023
BUY
$24.7 - $37.61 $64,294 - $97,898
2,603 Added 8.53%
33,125 $838,000
Q1 2023

Feb 07, 2025
SELL
$18.36 - $35.27 $66,756 - $128,241
-3,636 Reduced 10.64%
30,522 $983,000
Q4 2022

Feb 07, 2025
BUY
$18.32 - $30.66 $50,838 - $85,081
2,775 Added 10.0%
30,522 $563,000
Q4 2022

Feb 14, 2023
BUY
$18.32 - $30.66 $50,838 - $85,081
2,775 Added 10.0%
30,522 $563,000
Q3 2022

Feb 07, 2025
SELL
$14.33 - $28.47 $91,869 - $182,521
-6,411 Reduced 18.77%
27,747 $749,000
Q3 2022

Mar 03, 2023
SELL
$14.33 - $28.47 $39,765 - $79,004
-2,775 Reduced 9.09%
27,747 $749,000
Q3 2022

Nov 14, 2022
BUY
$14.33 - $28.47 $8,497 - $16,882
593 Added 2.18%
27,747 $749,000
Q2 2022

Aug 15, 2022
SELL
$11.52 - $20.4 $6,808 - $12,056
-591 Reduced 2.13%
27,154 $375,000
Q4 2021

Feb 14, 2022
BUY
$12.46 - $27.87 $4,074 - $9,113
327 Added 1.19%
27,745 $453,000
Q2 2021

Aug 16, 2021
SELL
$26.8 - $31.84 $7,262 - $8,628
-271 Reduced 0.98%
27,418 $813,000
Q1 2021

May 17, 2021
BUY
$24.03 - $29.97 $1,441 - $1,798
60 Added 0.22%
27,689 $774,000
Q4 2020

Feb 16, 2021
BUY
$23.41 - $28.34 $154,950 - $187,582
6,619 Added 31.5%
27,629 $783,000
Q3 2020

Nov 16, 2020
BUY
$23.23 - $34.3 $21,975 - $32,447
946 Added 4.71%
21,010 $528,000
Q2 2020

Aug 14, 2020
SELL
$12.6 - $26.55 $63,340 - $133,466
-5,027 Reduced 20.04%
20,064 $490,000
Q1 2020

May 15, 2020
BUY
$12.46 - $27.81 $40,532 - $90,465
3,253 Added 14.9%
25,091 $371,000
Q4 2019

Feb 14, 2020
BUY
$11.66 - $20.15 $62,147 - $107,399
5,330 Added 32.29%
21,838 $354,000
Q3 2019

Nov 14, 2019
BUY
$10.22 - $14.5 $7,491 - $10,628
733 Added 4.65%
16,508 $215,000
Q2 2019

Aug 14, 2019
BUY
$10.67 - $15.49 $23,143 - $33,597
2,169 Added 15.94%
15,775 $205,000
Q4 2018

Feb 14, 2019
BUY
$18.06 - $24.96 $21,184 - $29,278
1,173 Added 9.43%
13,606 $274,000
Q2 2018

Aug 14, 2018
BUY
$27.45 - $33.35 $56,025 - $68,067
2,041 Added 19.64%
12,433 $341,000
Q3 2017

Nov 14, 2017
BUY
$22.55 - $28.1 $234,339 - $292,015
10,392
10,392 $286,000

Others Institutions Holding RVNC

# of Institutions
208
Shares Held
80.9M
Call Options Held
2.26M
Put Options Held
5.48M
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email